Vermillion & White Wealth Management Group’s BioNTech BNTX Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20	Closed	-$1.9K	–	126
2025 Q4	$1.9K	Buy	+20	New	+$2.02K	﹤0.01%	499
2025 Q3	–	Sell	-20	Closed	-$2.13K	–	578
2025 Q2	$2.13K	Hold	20	–	–	﹤0.01%	457
2025 Q1	$1.82K	Hold	20	–	–	﹤0.01%	456
2024 Q4	$2.28K	Buy	+20	New	+$2.28K	﹤0.01%	317
2024 Q3	–	Sell	-20	Closed	-$1.61K	–	357
2024 Q2	$1.61K	Buy	+20	New	+$1.83K	﹤0.01%	313
2024 Q1	–	Sell	-20	Closed	-$2.11K	–	348
2023 Q4	$2.11K	Buy	+20	New	+$2.02K	﹤0.01%	246

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vermillion & White Wealth Management Group's BNTX Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 20 shares — an estimated $1.9K sold.

Vermillion & White Wealth Management Group first reported a position in BNTX in Q4 2023 and held it in 6 quarters. The position peaked at $2.28K in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Vermillion & White Wealth Management Group reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 20 BioNTech shares in Q1 2026, an estimated $1.9K.
Vermillion & White Wealth Management Group first reported a position in BioNTech in Q4 2023 and held it in 6 quarters.
Vermillion & White Wealth Management Group's BioNTech position peaked at $2.28K in Q4 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.